NASDAQ:CRNX

Crinetics Pharmaceuticals, Inc Earning Date

USA |NASDAQ |USD

CRNX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 4, 2021 Sep 2021 $-0.72 $-0.70 $-0.56
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 4, 2021 Sep 2021 $0.00 $5.60K $0.00

Crinetics Pharmaceuticals, Inc's next earnings date is Thursday, Nov 4, 2021 for the fiscal quarter ending Sep 2021.

CRNX Earnings Date & History Chart

CRNX Earnings & Revenue Forecast

CRNX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.74 $-0.88 $-0.63
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-2.86 $-3.07 $-2.70
Dec 2022 5 $-3.00 $-3.25 $-2.56

CRNX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.74 $-0.66 $-0.66
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.86 $-2.60 $-2.60
Dec 2022 0 / 0 $-3.00 $-2.88 $-2.88

CRNX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $0.00 $0.00 $0.00
Dec 2022 5 $0.00 $0.00 $0.00

CRNX Earnings Date & Revenue History

CRNX Earnings History

|
Show More
Show More

CRNX Revenue History

|
Show More
Show More

Crinetics Pharmaceuticals, Inc Next Earnings Date & Report

CRNX Next Earnings Date & Report Preview: Sep 2021 (FQ)

CRNX's next earnings date is Thursday, Nov 4, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 5 analysts, the average EPS estimation for Crinetics Pharmaceuticals, Inc's next quarterly earnings is $-0.72, with a low EPS estimation of $-0.78, and a high estimation of $-0.64.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.72, the last 2 month trend is $-0.65, and the 3 month trend is $-0.65.

Based on 5 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Crinetics Pharmaceuticals, Inc Previous Earnings Dates & Reports

CRNX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Crinetics Pharmaceuticals, Inc's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.

CRNX's earnings per share (EPS) was $-0.70, missing the consensus analysts forecast of $-0.60 by -16.09%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 1.45%, and lower than the same period a year before (Jun 2020) by 32.08%.

Revenues were $5.60K.

The company reported a net income of $-26.09M.

Free cash flow for the quarter was $-20.11M , compared to $-20.18M last quarter and $-15.87M a year before.

CRNX ended the quarter with $3.56M in total debt, a decrease of -6.07% compared to the previous quarter, and a decrease of -19.94% compared to the same quarter a year before.

CRNX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Crinetics Pharmaceuticals, Inc's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.

CRNX's earnings per share (EPS) was $-2.46, missing the consensus analysts forecast of $-2.35 by 4.68% , and lower than the previous year's EPS (Dec 2019) by 18.27%.

Revenues were $71.00, worse than the forecast of $70.00K by -99.90%, and down by -99.99% from previous year's revenue.

The company reported a net income of $-73.81K.

Crinetics Pharmaceuticals, Inc reported a free cash flow of $-62.21M for its fiscal year, compared to $-46.87M a year ago.

The company ended the fiscal year with $8.03M in total debt, an increase of 65.56% compared to the previous year.